Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.
VY® Morgan Stanley Global Franchise S IVGTX
- NAV / 1-Day Return 15.29 / +1.59 %
- Total Assets 301.5 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.200%
- Distribution Fee Level High
- Share Class Type No Load
- Category Global Large-Stock Blend
- Investment Style Large Growth
- Min. Initial Investment —
- Status Open
- TTM Yield 0.46%
- Turnover 15%
USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:12 PM GMT+0
Morningstar’s Analysis IVGTX
Will IVGTX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 48.7
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Microsoft Corp | 8.75 | 26.1 Mil | Technology |
SAP SE | 6.72 | 20.0 Mil | Technology |
Visa Inc Class A | 5.81 | 17.3 Mil | Financial Services |
Accenture PLC Class A | 5.03 | 15.0 Mil | Technology |
Intercontinental Exchange Inc | 4.42 | 13.2 Mil | Financial Services |
RELX PLC | 4.08 | 12.1 Mil | Industrials |
UnitedHealth Group Inc | 3.77 | 11.2 Mil | Healthcare |
Thermo Fisher Scientific Inc | 3.47 | 10.3 Mil | Healthcare |
Becton Dickinson & Co | 3.37 | 10.0 Mil | Healthcare |
Aon PLC Class A | 3.28 | 9.8 Mil | Financial Services |